Guru Ownership Trend
Guru Analysis for Crinetics Pharmaceuticals, Inc. (CRNX)
Crinetics Pharmaceuticals, Inc. (CRNX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $66.84 M.
Top institutional holders include Ken Fisher and Steven Cohen.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $727,301.54 net outflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Ken Fisher reduced exposure by 2.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Crinetics Pharmaceuticals, Inc. (CRNX)
Major holders include Ken Fisher ($27.75 M), Steven Cohen ($1.74 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 787,934 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $727,301.54, with 1 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited CRNX. The total reported sell value was $2.46 M.
Yes, 1 managers opened new positions in CRNX, and 0 increased their existing holdings. The total reported buy value was $1.74 M.